First Quadrant’s Anika Therapeutics ANIK Stock Holding History

First Quadrant’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-343	Closed	-$15K	–	502
2021 Q3	$15K	Hold	343	–	–	﹤0.01%	502
2021 Q2	$15K	Sell	343 -2,693	-89%	-$118K	﹤0.01%	499
2021 Q1	$124K	Sell	3,036 -1,046	-26%	-$42.7K	0.01%	402
2020 Q4	$185K	Hold	4,082	–	–	0.02%	362
2020 Q3	$144K	Hold	4,082	–	–	0.02%	390
2020 Q2	$154K	Buy	4,082 +57	+1%	+$2.15K	0.02%	464
2020 Q1	$116K	Sell	4,025 -5,192	-56%	-$150K	0.02%	441
2019 Q4	$478K	Buy	9,217 +37	+0.4%	+$1.92K	0.04%	318
2019 Q3	$504K	Sell	9,180 -847	-8%	-$46.5K	0.05%	308
2019 Q2	$407K	Hold	10,027	–	–	0.03%	431
2019 Q1	$303K	Hold	10,027	–	–	0.02%	434
2018 Q4	$337K	Hold	10,027	–	–	0.03%	426
2018 Q3	$423K	Sell	10,027 -3,373	-25%	-$142K	0.01%	516
2018 Q2	$429K	Hold	13,400	–	–	0.01%	508
2018 Q1	$666K	Hold	13,400	–	–	0.01%	448
2017 Q4	$722K	Hold	13,400	–	–	0.01%	490
2017 Q3	$777K	Hold	13,400	–	–	0.02%	486
2017 Q2	$661K	Hold	13,400	–	–	0.01%	497
2017 Q1	$582K	Hold	13,400	–	–	0.01%	518
2016 Q4	$656K	Hold	13,400	–	–	0.01%	502
2016 Q3	$641K	Hold	13,400	–	–	0.01%	507
2016 Q2	$719K	Hold	13,400	–	–	0.02%	438
2016 Q1	$599K	Sell	13,400 -1,300	-9%	-$58.1K	0.01%	470
2015 Q4	$561K	Buy	14,700 +500	+4%	+$19.1K	0.01%	459
2015 Q3	$452K	Hold	14,200	–	–	0.01%	467
2015 Q2	$469K	Sell	14,200 -11,200	-44%	-$370K	0.01%	478
2015 Q1	$1.05M	Hold	25,400	–	–	0.02%	342
2014 Q4	$1.04M	Hold	25,400	–	–	0.02%	349
2014 Q3	$931K	Hold	25,400	–	–	0.02%	371
2014 Q2	$1.18M	Buy	25,400 +9,500	+60%	+$440K	0.03%	358
2014 Q1	$653K	Buy	15,900 +1,700	+12%	+$69.8K	0.01%	416
2013 Q4	$542K	Sell	14,200 -6,600	-32%	-$252K	0.01%	455
2013 Q3	$497K	Buy	20,800 +3,300	+19%	+$78.9K	0.01%	458
2013 Q2	$298K	Buy	+17,500	New	+$298K	0.01%	498